Halsall D J, Halligan E P, Elsey T S, Cox T M
Department of Clinical Biochemistry, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ UK.
Hum Mutat. 1999 Nov;14(5):447. doi: 10.1002/(SICI)1098-1004(199911)14:5<447::AID-HUMU12>3.0.CO;2-1.
The majority of mutations identified in patients with Metachromatic leucodystrophy are unique to individual families. We report here a new mutation in the arylsulphatase A gene (D281Y) identified in a patient with late-onset Metachromatic leucodystrophy. This mutation was inherited in cis with the common pseudo-deficiency allele and in trans with the previously described I179S (250100.0008) mutation which complicated the enzymatic diagnosis of this condition. Sequence comparison shows D281 to be highly conserved amongst the arylsulphatases. The clinical features of this patient which are predominantly of a slowly progressive psychiatric and intellectual deterioration rather than rapid neurological impairment are typical of I179S compound heterozygotes.
在异染性脑白质营养不良患者中鉴定出的大多数突变是各个家庭所特有的。我们在此报告一名迟发性异染性脑白质营养不良患者中鉴定出的芳基硫酸酯酶A基因新突变(D281Y)。该突变与常见的假缺陷等位基因顺式遗传,与先前描述的I179S(250100.0008)突变反式遗传,这使得该疾病的酶学诊断变得复杂。序列比较显示D281在芳基硫酸酯酶中高度保守。该患者的临床特征主要是缓慢进展的精神和智力衰退,而非快速的神经功能损害,这是I179S复合杂合子的典型表现。